Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_assertion type Assertion NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_head.
- NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_assertion wasGeneratedBy ECO_0000203 NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_provenance.
- NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_assertion wasDerivedFrom befree-2016 NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_provenance.
- NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_assertion SIO_000772 17124058 NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_provenance.
- NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_assertion evidence source_evidence_literature NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_provenance.
- NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_assertion description "[The difference in responses of chronic myeloid leukemia (CML) patients to BCR-ABL inhibitors compared to FLT3 mutant AML patients to FLT3 inhibitors may be reflective of treating a single gene disease in CML versus multiply altered gene disease in AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580848.RAi754E32uqhdRxtUSbSrDpVe2OZyXlxTEGCtyBe7sZZw130_provenance.